Company / Net Income
LEXICON PHARMACEUTICALS, INC. Net Income History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$177.1M
FY2025
5-year range
-$177.1M / -$58.6M
FY2021-FY2025
Trend
-73.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 3 consecutive years, from -$59M in FY2019 to -$177M in FY2025.
Based on SEC 10-K filings.
-$177M in FY2025.
Declined from -$88M to -$177M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- LEXICON PHARMACEUTICALS, INC.'s net income has declined for 3 consecutive years.
- In FY2025, net income decreased 73.7% year-over-year.
- Peak net income was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$177.1M | -73.7% |
| FY2024 | -$101.9M | -16.2% |
| FY2023 | -$87.8M | -49.8% |
| FY2019 | -$58.6M | +55.4% |
| FY2018 | -$131.4M | -2707.5% |
| FY2017 | -$4.7M | +95.3% |
| FY2016 | -$100.3M | +3.7% |
| FY2015 | -$104.1M | +5.5% |
| FY2014 | -$110.2M | +5.2% |
| FY2013 | -$116.2M | -14.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026